Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 58Anemia, Refractory, with Excess of Blasts 49Myelodysplastic Syndromes 44Venous Thromboembolism 33Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Anemia, Aplastic 26Myeloproliferative Disorders 25Lymphoma, Non-Hodgkin 23Neoplasms 22Multiple Myeloma 21Leukemia, Myelogenous, Chronic, BCR-ABL Positive 20Anemia 20Leukemia, Myelomonocytic, Chronic 19Hodgkin Disease 19Thrombocytopenia 18Primary Myelofibrosis 18Leukemia, Lymphocytic, Chronic, B-Cell 18Leukemia 18Hematologic Neoplasms 17Lymphoma 15Anemia, Sickle Cell 13Lymphoma, Follicular 11Fanconi Anemia 11Cytopenia 11Venous Thrombosis 10Febrile Neutropenia 10Bone Marrow Failure Disorders 10Pulmonary Embolism 9Leukemia, Biphenotypic, Acute 9Polycythemia Vera 8

Interventions

oprelvekin 1Interleukin-11 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
CTIT: Cancer Therapy Induced Thrombocytopenia × Classical hematology × 1 year × Clear all
NCT06759636 2026-04-14

FRIENDS-01

The First Affiliated Hospital with Nanjing Medical University

Phase 3 Recruiting
88 enrolled
Classical hematology

CTIT: Cancer Therapy Induced Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡